A detailed history of Eco R1 Capital, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Eco R1 Capital, LLC holds 500,000 shares of IONS stock, worth $17 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
500,000
Holding current value
$17 Million
% of portfolio
0.87%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.06 - $51.86 $20 Million - $25.9 Million
500,000 New
500,000 $20 Million
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $9.77 Million - $12.7 Million
-208,609 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$41.6 - $63.4 $8.68 Million - $13.2 Million
208,609 New
208,609 $9.86 Million
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $38.4 Million - $58.9 Million
-725,326 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $28.3 Million - $38.9 Million
653,000 Added 902.86%
725,326 $39.2 Million
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $3.1 Million - $3.88 Million
72,326 New
72,326 $3.73 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.